Back to all studies
RecruitingNCT06197711

The Short-term Effects of PRISMA on Mental Health

This study is recruiting. It focuses on depression and currently lists participation information in Switzerland.

Depression, Anxiety, ...BehavioralOver 18 Years
Need help deciding?

Ask HopeStage to review this study with me

Loading the security check...
Study ID: NCT06197711. We help you review the study, but cannot decide medical eligibility.
In plain English

Key information made simple

This observational study is following people with Psychological Distress, Anxiety, Depression, or Suicidal Ideation to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information. This study may not offer a new treatment, and its main value is helping researchers learn from follow-up information that may improve future care.

What to expect

Your next step

The official record suggests in-person participation through a hospital, with sites including University Hospital Zurich. Participation appears to involve assessments along with scans or samples to help researchers understand patterns more clearly. The main fit is usually meeting the main study requirements, while common reasons not to take part include safety concerns that need urgent care first and other factors that could make participation unsuitable. The official record does not list a formal phase, which usually means this is focused more on feasibility, delivery, or support than a standard drug-development stage.

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: January 22, 2024
Recruitment status
Recruiting
Estimated enrollment
Not clearly listed
Sponsor
University of Zurich
Sponsor type
University
Study type
Behavioral
Intervention type
Behavioral / psychological / psychosocial
Study phase
Not clearly listed
Locations
Switzerland
Age range
Over 18 Years
Official registry ID
NCT06197711
Official source
Official registry link

Want help reviewing this study?

Loading the security check...
Study ID: NCT06197711. We help you review the study, but cannot decide medical eligibility.
Why this study may matter

Why this study may matter

This study may matter because it adds public evidence around depression. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.

In practice

For you

Taking part may help test a support approach in real life.

It requires regular visits and structured follow-up.

Requires travel, with in-person participation in Switzerland.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring behavioral or lifestyle intervention for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

What is a behavioral study?

This appears to be a behavioral / psychological / psychosocial study. Phase is mainly useful to check for medication studies and some device studies.

Who might this study be for?

This study may concern people with depression; age range: Over 18 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may take part in sessions or exercises related to habits, thoughts, emotions, or behaviors. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

Could this study affect my mood, habits, motivation, or stress?

Behavioral studies can involve habits, emotions, motivation, stress, sleep, or ways of thinking. Ask whether the intervention could affect your mood or stress, and who to contact if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by University of Zurich, which appears to be a university. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The registry indicates that this study is currently recruiting. This does not mean you are eligible: the study team must confirm the criteria, available locations, and next steps.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
The Short-term Effects of PRISMA on Mental Health — Depression Clinical Trial | HopeStage